Patient demographics
| Crohn’s cohort | N = 45 |
|---|---|
| Female, n (%) Male | 25 (55%) 20 (45%) |
| Median age at time of testing, years | 36.5 (18–75) |
| Smoking status, n (%) Current Non-smokers | 7 (16%) 38 (84%) |
| Panenteric Ileocolonic Ileal Perianal Colonic | 18 (40%) 9 (20%) 8 (18%) 6 (13%) 4 (9%) |
| Anti-TNF treatment Infliximab Adalimumab | 26 (58%) 19 (42%) |
| Anti TNF monotherapy Thiopurines Methotrexate Corticosteroids (>20mg/daily) | 22 (49%) 19 (42%) 2 (4.5%) 2 (4.5%) |